Inflammation and Endometriosis

Endometriosis: Science and Practice

Volumn , Issue , 2012, Pages 255-262

  Hornung, Daniela ^a   von Wussow, Ursula ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Activated macrophage increase; CRP, SAA elevation; Endometriosis; Inflammation; Interleukin 1; MCP 1; Platelet, growth factor; SICAM 1 in serum; TGF ; Tumor necrosis factors

Indexed keywords

EID: 84886978177     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398519.ch24     Document Type: Chapter

References (126)

1. Abrao MS, Podgaec S, Filho BM et al. The use of biochemical markers in the diagnosis of pelvic endometriosis Hum Reprod 1997;12:2523-2527.
2. Gleicher N, Pratt D, Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity 1993;16:115-140.
3. Dmowski WP. Immunological aspects of endometriosis. Int J Gynaecol Obstet 1995;50(Suppl 1):S3-10.
4. Xavier P, Belo L, Beires J et al. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006;273:227-231.
5. Lermann J, Mueller A, Korber F et al. Evaluation of high-sensitivity C-reactive protein in comparison with C-reactive protein as biochemical serum markers in women with endometriosis. Fertil Steril 2010;93(7):2125-2129.
6. Agic A, Xu H, Finas D et al. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006;62:139-147.
7. Meek SC, Hodge DD, Musich JR. Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol 1988;158:1365-1373.
8. Gleicher N, El Roeiy A, Confino E et al. Is endometriosis an autoimmune disease? Obstet Gynecol 1987;70:115-122.
9. Badawy SZ, Cuenca V, Kaufman L et al. The regulation of immunoglobulin production by B cells in patients with endometriosis. Fertil Steril 1989;51:770-773.
10. Taylor PV, Maloney MD, Campbell JM et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991;98:680-684.
11. Badawy SZ, Cuenca V, Marshall L et al. Cellular components in peritoneal fluid in infertile patients with and without endometriosis. Fertil Steril 1984;42:704-708.
12. Gilmore SM, Aksel S, Hoff C et al. In vitro lymphocyte activity in women with endometriosis - an altered immune response? Fertil Steril 1992;58:1148-1152.
13. Nomiyama M, Hachisuga T, Sou H et al. Local immune response in infertile patients with minimal endometriosis. Gynecol Obstet Invest 1997;44:32-37.
14. Vinatier D, Dufour P, Oosterlynck D. Immunological aspects of endometriosis. Hum Reprod Update 1996;2:371-384.
15. Bartosik D, Damjanov I, Viscarello RR et al. Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4. Am J Obstet Gynecol 1987;156:11-15.
16. D'Cruz OJ, Wild RA Evaluation of endometrial tissue specific complement activation in women with endometriosis. Fertil Steril 1992;57:787-795.
17. Isaacson KB, Galman M, Coutifaris C et al. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril 1990;53:836-841.
18. Isaacson KB, Xu Q, Lyttle CR. The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue. Fertil Steril 1991;55:395-402.
19. Bischof P, Planas-Basset D, Meisser A et al. Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). Hum Reprod 1994;9:1652-1659. Part 4 Biological Basis and Pathophysiology of Endometriosis 260
20. Braun DP, Gebel H, House R et al. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996;65:1125-1129.
21. Ho HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997;38:400-412.
22. Oosterlynck DJ, Meuleman C, Lacquet FA et al. Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. Am J Reprod Immunol 1994;31:25-31.
23. Wu MY, Chao KH, Chen SU et al. The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol 1996;35:510-516.
24. Becker JL, Widen RH, Mahan CS et al. Human peritoneal macrophage and T lymphocyte populations in mild and severe endometriosis. Am J Reprod Immunol 1995;34:179-187.
25. Oosterlynck DJ, Meuleman C, Waer M et al. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992;58:290.
26. Gagné D, Rivard M, Page M et al. Blood leukocyte subsets are modulated in patients with endometriosis. Fertil Steril 2003;80:43-53.
27. Khorram O, Taylor RN, Ryan IP et al. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993;169:1545-1549.
28. Oral E, Olive DL, Arici A The peritoneal environment in endometriosis. Hum Reprod Update 1996;2:385-398.
29. Hornung D, Bentzien F, Wallwiener D et al. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod 2001;7:163-168.
30. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-226.
31. Lousse JC, van Langendonckt A, Gonzalez-Ramos R et al. Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril 2008;90:217-220.
32. Nowak NM, Fischer OM, Gust TC et al. Intraperitoneal inflammation decreases endometriosis in a mouse model. Hum Reprod 2008;23:2466-2474.
33. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004;95:930-935.
34. Braun DP, Muriana A, Gebel H et al. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994;61:78-84.
35. Griffith JS, Liu YG, Tekmal RR et al. Menstrual endometrial cells from women with endometriosis demonstrate increased adherence to peritoneal cells and increased expression of CD44 splice variants. Fertil Steril 2010;93(6):1745-1749.
36. Hever A, Roth RB, Hevezi P et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci USA 2007;104:12451-12456.
37. Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol 2005;57:237-248.
38. Ho HN, Chao KH, Chen HF et al. Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995;10:2671-2675.
39. Oosterlynck DJ, Cornillie FJ, Waer M et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
40. Hassa H, Tanir HM, Tekin B et al. Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and latestaged endometriosis. Arch Gynecol Obstet 2009;279:891-895.
41. Schall TJ, Bacon K, Toy KJ et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-671.
42. Ortiz BD, Krensky AM, Nelson PJ et al. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol 1996;16:202-210.
43. Nikolcheva T, Pyronnet S, Chou SY et al. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest 2002;110:119-126.
44. Nikolcheva T, Pyronnet S, Chou SY et al. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest 2002;110:119-126.
45. Nikolcheva T, Pyronnet S, Chou SY et al. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest 2002;110:119-126.
46. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10.
47. Lebovic DI, Chao VA, Martini JF et al. IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter. J Clin Endocrinol Metab 2001;86:4759-4764.
48. Lebovic DI, Chao VA, Taylor RN. Peritoneal macrophages induce RANTES (regulated on activation, normal T cell expressed and secreted) chemokine gene transcription in endometrial stromal cells. J Clin Endocrinol Metab 2004;89:1397-1401.
49. Fang CL, Han SP, Fu SL et al. Ectopic, autologous eutopic and normal endometrial stromal cells have altered expression and chemotactic activity of RANTES. Eur J Obstet Gynecol Reprod Biol 2009;143:55-60.
50. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
51. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
52. Kalu E, Sumar N, Giannopoulos T et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res 2007;33:490-495.
53. Agic A, Xu H, Rehbein M et al. Cognate chemokine receptor 1 messenger ribonucleic acid expression in peripheral blood as a diagnostic test for endometriosis. Fertil Steril 2007;87:982-984.
54. Wieser F, Dogan S, Klingel K et al. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. Fertil Steril 2005;83:1878-1881.
55. Agic A, Djalali S, Wolfler MM et al. Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci 2008;15:906-911.
56. Philippeaux MM, Piguet PF. Expression of tumor necrosis factoralpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993;143:480-486.
57. Hunt JS, Chen HL, Hu XL et al. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992;47:141-147.
58. Laird SM, Tuckerman EM, Saravelos H et al. The production of tumour necrosis factor alpha (TNF-alpha) by human endometrial cells in culture. Hum Reprod 1996;11:1318-1323.
59. Chen DB, Yang ZM, Hilsenrath R et al. Stimulation of prostaglandin (PG) F2 alpha and PGE2 release by tumour necrosis factor-alpha and interleukin-1 alpha in cultured human luteal phase endometrial cells. Hum Reprod 1995;10:2773-2780.
60. Zhang RJ, Wild RA, Ojago JM. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril 1993;59:1196-1201.
61. Iwabe T, Harada T, Tsudo T et al. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin- 8 gene and protein expression. J Clin Endocrinol Metab 2000;85:824-829.
62. Eisermann J, Gast MJ, Pineda J et al. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988;50:573-579.
63. Calhaz-Jorge C, Costa AP, Barata M et al. Tumour necrosis factor alpha concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions. Hum Reprod 2000;15:1256-1260.
64. Pizzo A, Salmeri FM, Ardita FV et al. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 2002;54:82-87.
65. Bedaiwy MA, Falcone T, Sharma RK et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002;17:426-431.
66. Yoshimura T, Leonard E. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J Immunol 1990;144:2377-2383.
67. Yoshimura T, Yuhki N, Moore SK et al. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487-493.
68. Arici A, Oral E, Attar E et al. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril 1997;67:1065-1072.
69. Akoum A, Lemay A, McColl SR et al. Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis. Le Groupe d'Investigation en Gynecologie. Am J Obstet Gynecol 1996;175:1620-1625.
70. Gmyrek GB, Sieradzka U, Goluda M et al. Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest 2008;37:43-61.
71. Osuga Y, Hirota Y, Taketani Y. Basic and translational research on proteinase-activated receptors: proteinase-activated receptors in female reproductive tissues and endometriosis. J Pharmacol Sci 2008;108:422-425.
72. Ulukus M, Ulukus EC, Tavmergen Goker EN et al. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril 2009;91:687-693.
73. Gmyrek GB, Sozanski R, Jerzak M et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2005;122:199-205.
74. Haddad GF, Jodicke C, Thomas MA et al. Case series of rosiglitazone used during the first trimester of pregnancy. Reprod Toxicol 2008;26:183-184.
75. Luo X, Xu J, Chegini N. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta. J Clin Endocrinol Metab 2003;88:4967-4976.
76. Hammond MG, Oh ST, Anners J et al. The effect of growth factors on the proliferation of human endometrial stromal cells in culture. Am J Obstet Gynecol 1993;168:1131-1136.
77. Oosterlynck DJ, Meuleman C, Sobis H et al. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 1993;59:778-782.
78. Liu YG, Tekmal RR, Binkley PA et al. Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta. Mol Hum Reprod 2009;15:665-673.
79. Keenan JA, Chen TT, Chadwell NL et al. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1985;34:381-385.
80. Punnonen J, Teisala K, Ranta H et al. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 1986;174:1522-1526.
81. Gazvani MR, Christmas S, Quenby S et al. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod 1998;13:1957-1961.
82. Garcia-Velasco JA, Arici A. Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. Mol Hum Reprod 1999;5:1135-1140.
83. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003;49:285-296.
84. Senturk LM, Arici A. Immunology of endometriosis. J Reprod Immunol 1999;43:67-83.
85. Sokolov DI, Solodovnikova NG, Pavlov OV et al. Study of cytokine profile and angiogenic potential of peritoneal fluid in patients with external genital endometriosis. Bull Exp Biol Med 2005;140:541-544.
86. Akoum A, Al Akoum M, Lemay A et al. Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain. Fertil Steril 2008;89:1618-1624.
87. Tabibzadeh SS, Santhanam U, Sehgal PB et al. Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol 1989;142:3134-3139.
88. Laird SM, Li TC, Bolton AE. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum Reprod 1993;8:793-798. Part 4 Biological Basis and Pathophysiology of Endometriosis 262
89. Ray P, Ghosh SK, Zhang DH et al. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997;409:79-85.
90. Sironi M, Breviario F, Proserpio P et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989;142:549-553.
91. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
92. Giudice LC Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 1994;61:1-17.
93. Lebovic DI, Bentzien F, Chao VA et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin- 1beta. Mol Hum Reprod 2000;6:269-275.
94. Zarmakoupis PN, Rier SE, Maroulis GB et al. Inhibition of human endometrial stromal cell proliferation by interleukin 6. Hum Reprod 1995;10:2395-2399.
95. Yoshioka H, Harada T, Iwabe T et al. Menstrual cycle-specific inhibition of the proliferation of endometrial stromal cells by interleukin 6 and its soluble receptor. Am J Obstet Gynecol 1999;180:1088-1094.
96. Keenan JA, Chen TT, Chadwell NL et al. Interferon-gamma (IFNgamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophageconditioned media of women with endometriosis. Am J Reprod Immunol 1994;32:180-183.
97. Buyalos RP, Funari VA, Azziz R et al. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. Fertil Steril 1992;58:302-306.
98. Rapkin A, Morgan M, Bonpane C et al. Peritoneal fluid interleukin-6 in women with chronic pelvic pain. Fertil Steril 2000;74:325-328.
99. Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophagederived mediator of angiogenesis. Science 1992;258:1798-1801.
100. Martinez S, Garrido N, Coperias JL et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 2007;22:836-842.
101. Othman E, Hornung D, Salem HT et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 2008;137:240-246.
102. Ryan IP, Tseng JF, Schriock ED et al. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995;63:929-932.
103. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein- 1 (MCP-1). Immunol Today 1990;11:97-101.
104. Rana N, Braun DP, House R et al. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 1996;65:925-930.
105. Becker CM, d'Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 2007;74:121-130.
106. Li XF, Gregory J, Ahmed A. Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors 1994;11:277-282.
107. Torry DS, Holt VJ, Keenan JA et al. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 1996;66:72-80.
108. Shifren JL, Tseng JF, Zaloudek CJ et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-3118.
109. Brogi E, Wu T, Namiki A et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652.
110. Ben-Av P, Crofford LJ, Wilder RL et al. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-87.
111. Lin YJ, Lai MD, Lei HY et al. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 2006;147:1278-1286.
112. Hornung D, Lebovic DI, Shifren JL et al. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril 1998;69:909-915.
113. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100.
114. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-223.
115. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996;98:482-489.
116. Donnez J, Smoes P, Gillerot S et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-1690.
117. Gargett CE, Chan RW, Schwab KE. Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol 2008;288:22-29.
118. Garcia-Velasco JA, Arici A, Zreik T et al. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999;5:642-650.
119. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
120. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998;4:741-751.
121. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998;4:741-751.
122. Daniel Y, Geva E, Amit A et al. Do soluble cell adhesion molecules play a role in endometriosis? Am J Reprod Immunol 2000;43:160-166.
123. Wu MH, Yang BC, Hsu CC et al. The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil Steril 1998;70:1139-1142.
124. Leng J, Lang J, Zhao D et al. Serum levels of soluble intercellular molecule 1 (sICAM-1) in endometriosis. Zhonghua Yi Xue Za Zhi 2002;82:189-190.
125. Barrier BF, Sharpe-Timms KL. Expression of soluble adhesion molecules in sera of women with stage III and IV endometriosis. J Soc Gynecol Invest 2002;9:98-101.
126. De Placido G, Alviggi C, di Palma G et al. Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. Hum Reprod 1998;13:3206-3210.